Oliver Fellechner and Irina Smirnova
Can. J. Chem. Eng., 2021, 99, pp. 1035-1049.
Biotransformations may face obstacles such as product inhibition, product toxicity, or unfavourable reaction equilibria that prevent complete conversion. One way to tackle this is enzyme engineering, which has made tremendous progress in the recent past. Additonally, in situ product removal (ISPR) can pose an attractive complementary strategy. The authors of this work have demonstrated concurrent enzymatic reaction and ISPR, referred to as 'extractive biocatalysis'. For the ISPR, the authors evaluated the use of aqueous micellar two-phase systems (AMTPS) for extractive purposes. As model reaction, Penicillin G hydrolysis by CalB lipase was used to demonstrate continuous, heterogeneous extractive biocatalysis by means of cloud point extraction.
Highlights:
Industries Pharmaceuticals and Cosmetics
Topics Biocatalysis, Process Development, Scientific Literature
Products SpinChem® RBR S2